Single-agent paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. London Gynaecological Oncology and North Thames Gynaecological Oncology Groups.

The aim of this study was to evaluate the efficacy of high-dose paclitaxel in patients with previously untreated stage IV epithelial ovarian cancer. Paclitaxel was administered intravenously over 3 h at a dose of 225 mg m(-2) on a 21-day cycle for six courses. Thirty-six patients were entered into t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gore, M. E., Rustin, G., Slevin, M., Gallagher, C., Penson, R., Osborne, R., Ledermann, J., Cameron, T., Thompson, J. M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group|1 1997
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2063326/
https://ncbi.nlm.nih.gov/pubmed/9043029
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak